Growth Metrics

NovaBridge Biosciences (NBP) Liabilities from Discontinued Operations (2023)

NovaBridge Biosciences (NBP) reported Liabilities from Discontinued Operations of 49669000.0 for Q4 2023.

NovaBridge Biosciences (NBP) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 49669000.0 in Q4 2023.

  • Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 49669000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 49669000.0 (changed N/A YoY) and the FY2023 annual result came in at 49669000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations was little changed at 49669000.0 in Q4 2023 per NBP's latest filing.
  • Across five years, Liabilities from Discontinued Operations topped out at 49669000.0 in Q4 2023 and bottomed at 49669000.0 in Q4 2023.

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 -49.67 Mn
Dec 31, 2023 -49.67 Mn